世界の自己免疫性溶血性貧血治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autoimmune Hemolytic Anemia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3871 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、自己免疫性溶血性貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・自己免疫性溶血性貧血治療薬の市場動向 ・企業の競争状況、市場シェア ・自己免疫性溶血性貧血治療薬の種類別市場規模と予測2016-2027（コルチコステロイド、モノクローナル抗体、その他） ・自己免疫性溶血性貧血治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・自己免疫性溶血性貧血治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・自己免疫性溶血性貧血治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・自己免疫性溶血性貧血治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自己免疫性溶血性貧血治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・自己免疫性溶血性貧血治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amneal Pharmaceuticals Inc、Baxter International Inc、F. Hoffmann-La Roche Ltd、Incyte Corp、Kezar Life Sciences Inc、Pfizer Inc、Rigel Pharmaceuticals Inc、Sanofi、Teva Pharmaceutical Industries Ltd、Horizo​​n、Genentech、Zydus Cadila、Concord Biotech） ・結論

Autoimmune Hemolytic Anemia (AHA) is also called immune hemolytic anemia. It is an immune and rare red blood cell disorder. Autoimmune hemolytic anemia occurs when the immune system makes antibodies that attack red blood cells in the body. This decreases the number of red blood cells, resulting to hemolytic anemia.

Market Analysis and Insights: Global Autoimmune Hemolytic Anemia Therapeutics Market
The global Autoimmune Hemolytic Anemia Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Hemolytic Anemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Hemolytic Anemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Hemolytic Anemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Hemolytic Anemia Therapeutics market.

Global Autoimmune Hemolytic Anemia Therapeutics Scope and Market Size
Autoimmune Hemolytic Anemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Hemolytic Anemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Drug Class
Corticosteroids
Monoclonal Antibodies
Others
By Disease Type
Cold Antibody Hemolytic Anemia
Warm Antibody Hemolytic Anemia

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amneal Pharmaceuticals Inc
Baxter International Inc
F. Hoffmann-La Roche Ltd
Incyte Corp
Kezar Life Sciences Inc
Pfizer Inc
Rigel Pharmaceuticals Inc
Sanofi
Teva Pharmaceutical Industries Ltd
Horizo​​n
Genentech
Zydus Cadila
Concord Biotech

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Hemolytic Anemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Monoclonal Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Hemolytic Anemia Therapeutics Market Perspective (2016-2027)
2.2 Autoimmune Hemolytic Anemia Therapeutics Growth Trends by Regions
2.2.1 Autoimmune Hemolytic Anemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Hemolytic Anemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Hemolytic Anemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Hemolytic Anemia Therapeutics Industry Dynamic
2.3.1 Autoimmune Hemolytic Anemia Therapeutics Market Trends
2.3.2 Autoimmune Hemolytic Anemia Therapeutics Market Drivers
2.3.3 Autoimmune Hemolytic Anemia Therapeutics Market Challenges
2.3.4 Autoimmune Hemolytic Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Hemolytic Anemia Therapeutics Players by Revenue
3.1.1 Global Top Autoimmune Hemolytic Anemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Hemolytic Anemia Therapeutics Revenue
3.4 Global Autoimmune Hemolytic Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Autoimmune Hemolytic Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Hemolytic Anemia Therapeutics Revenue in 2020
3.5 Autoimmune Hemolytic Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Autoimmune Hemolytic Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Autoimmune Hemolytic Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Hemolytic Anemia Therapeutics Breakdown Data by Type
4.1 Global Autoimmune Hemolytic Anemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Hemolytic Anemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Autoimmune Hemolytic Anemia Therapeutics Breakdown Data by Application
5.1 Global Autoimmune Hemolytic Anemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Hemolytic Anemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autoimmune Hemolytic Anemia Therapeutics Market Size (2016-2027)
6.2 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type
6.2.1 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application
6.3.1 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country
6.4.1 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size (2016-2027)
7.2 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Type
7.2.1 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Application
7.3.1 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Country
7.4.1 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size (2016-2027)
9.2 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type
9.2.1 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application
9.3.1 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country
9.4.1 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amneal Pharmaceuticals Inc
11.1.1 Amneal Pharmaceuticals Inc Company Details
11.1.2 Amneal Pharmaceuticals Inc Business Overview
11.1.3 Amneal Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Introduction
11.1.4 Amneal Pharmaceuticals Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.1.5 Amneal Pharmaceuticals Inc Recent Development
11.2 Baxter International Inc
11.2.1 Baxter International Inc Company Details
11.2.2 Baxter International Inc Business Overview
11.2.3 Baxter International Inc Autoimmune Hemolytic Anemia Therapeutics Introduction
11.2.4 Baxter International Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.2.5 Baxter International Inc Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Autoimmune Hemolytic Anemia Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Incyte Corp
11.4.1 Incyte Corp Company Details
11.4.2 Incyte Corp Business Overview
11.4.3 Incyte Corp Autoimmune Hemolytic Anemia Therapeutics Introduction
11.4.4 Incyte Corp Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.4.5 Incyte Corp Recent Development
11.5 Kezar Life Sciences Inc
11.5.1 Kezar Life Sciences Inc Company Details
11.5.2 Kezar Life Sciences Inc Business Overview
11.5.3 Kezar Life Sciences Inc Autoimmune Hemolytic Anemia Therapeutics Introduction
11.5.4 Kezar Life Sciences Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.5.5 Kezar Life Sciences Inc Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Autoimmune Hemolytic Anemia Therapeutics Introduction
11.6.4 Pfizer Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.6.5 Pfizer Inc Recent Development
11.7 Rigel Pharmaceuticals Inc
11.7.1 Rigel Pharmaceuticals Inc Company Details
11.7.2 Rigel Pharmaceuticals Inc Business Overview
11.7.3 Rigel Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Introduction
11.7.4 Rigel Pharmaceuticals Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.7.5 Rigel Pharmaceuticals Inc Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Autoimmune Hemolytic Anemia Therapeutics Introduction
11.8.4 Sanofi Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceutical Industries Ltd
11.9.1 Teva Pharmaceutical Industries Ltd Company Details
11.9.2 Teva Pharmaceutical Industries Ltd Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd Autoimmune Hemolytic Anemia Therapeutics Introduction
11.9.4 Teva Pharmaceutical Industries Ltd Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Ltd Recent Development
11.10 Horizo​​n
11.10.1 Horizo​​n Company Details
11.10.2 Horizo​​n Business Overview
11.10.3 Horizo​​n Autoimmune Hemolytic Anemia Therapeutics Introduction
11.10.4 Horizo​​n Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.10.5 Horizo​​n Recent Development
11.11 Genentech
11.11.1 Genentech Company Details
11.11.2 Genentech Business Overview
11.11.3 Genentech Autoimmune Hemolytic Anemia Therapeutics Introduction
11.11.4 Genentech Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.11.5 Genentech Recent Development
11.12 Zydus Cadila
11.12.1 Zydus Cadila Company Details
11.12.2 Zydus Cadila Business Overview
11.12.3 Zydus Cadila Autoimmune Hemolytic Anemia Therapeutics Introduction
11.12.4 Zydus Cadila Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.12.5 Zydus Cadila Recent Development
11.13 Concord Biotech
11.13.1 Concord Biotech Company Details
11.13.2 Concord Biotech Business Overview
11.13.3 Concord Biotech Autoimmune Hemolytic Anemia Therapeutics Introduction
11.13.4 Concord Biotech Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
11.13.5 Concord Biotech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autoimmune Hemolytic Anemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Others
Table 5. Global Autoimmune Hemolytic Anemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autoimmune Hemolytic Anemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Autoimmune Hemolytic Anemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Autoimmune Hemolytic Anemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Regions (2022-2027)
Table 11. Autoimmune Hemolytic Anemia Therapeutics Market Trends
Table 12. Autoimmune Hemolytic Anemia Therapeutics Market Drivers
Table 13. Autoimmune Hemolytic Anemia Therapeutics Market Challenges
Table 14. Autoimmune Hemolytic Anemia Therapeutics Market Restraints
Table 15. Global Autoimmune Hemolytic Anemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Autoimmune Hemolytic Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Hemolytic Anemia Therapeutics as of 2020)
Table 18. Ranking of Global Top Autoimmune Hemolytic Anemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Autoimmune Hemolytic Anemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Autoimmune Hemolytic Anemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Autoimmune Hemolytic Anemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Autoimmune Hemolytic Anemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Autoimmune Hemolytic Anemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Autoimmune Hemolytic Anemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amneal Pharmaceuticals Inc Company Details
Table 63. Amneal Pharmaceuticals Inc Business Overview
Table 64. Amneal Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Product
Table 65. Amneal Pharmaceuticals Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Amneal Pharmaceuticals Inc Recent Development
Table 67. Baxter International Inc Company Details
Table 68. Baxter International Inc Business Overview
Table 69. Baxter International Inc Autoimmune Hemolytic Anemia Therapeutics Product
Table 70. Baxter International Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Baxter International Inc Recent Development
Table 72. F. Hoffmann-La Roche Ltd Company Details
Table 73. F. Hoffmann-La Roche Ltd Business Overview
Table 74. F. Hoffmann-La Roche Ltd Autoimmune Hemolytic Anemia Therapeutics Product
Table 75. F. Hoffmann-La Roche Ltd Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd Recent Development
Table 77. Incyte Corp Company Details
Table 78. Incyte Corp Business Overview
Table 79. Incyte Corp Autoimmune Hemolytic Anemia Therapeutics Product
Table 80. Incyte Corp Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Incyte Corp Recent Development
Table 82. Kezar Life Sciences Inc Company Details
Table 83. Kezar Life Sciences Inc Business Overview
Table 84. Kezar Life Sciences Inc Autoimmune Hemolytic Anemia Therapeutics Product
Table 85. Kezar Life Sciences Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Kezar Life Sciences Inc Recent Development
Table 87. Pfizer Inc Company Details
Table 88. Pfizer Inc Business Overview
Table 89. Pfizer Inc Autoimmune Hemolytic Anemia Therapeutics Product
Table 90. Pfizer Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Pfizer Inc Recent Development
Table 92. Rigel Pharmaceuticals Inc Company Details
Table 93. Rigel Pharmaceuticals Inc Business Overview
Table 94. Rigel Pharmaceuticals Inc Autoimmune Hemolytic Anemia Therapeutics Product
Table 95. Rigel Pharmaceuticals Inc Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Rigel Pharmaceuticals Inc Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sanofi Recent Development
Table 101. Teva Pharmaceutical Industries Ltd Company Details
Table 102. Teva Pharmaceutical Industries Ltd Business Overview
Table 103. Teva Pharmaceutical Industries Ltd Autoimmune Hemolytic Anemia Therapeutics Product
Table 104. Teva Pharmaceutical Industries Ltd Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceutical Industries Ltd Recent Development
Table 106. Horizo​​n Company Details
Table 107. Horizo​​n Business Overview
Table 108. Horizo​​n Autoimmune Hemolytic Anemia Therapeutics Product
Table 109. Horizo​​n Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Horizo​​n Recent Development
Table 111. Genentech Company Details
Table 112. Genentech Business Overview
Table 113. Genentech Autoimmune Hemolytic Anemia Therapeutics Product
Table 114. Genentech Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Genentech Recent Development
Table 116. Zydus Cadila Company Details
Table 117. Zydus Cadila Business Overview
Table 118. Zydus Cadila Autoimmune Hemolytic Anemia Therapeutics Product
Table 119. Zydus Cadila Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Zydus Cadila Recent Development
Table 121. Concord Biotech Company Details
Table 122. Concord Biotech Business Overview
Table 123. Concord Biotech Autoimmune Hemolytic Anemia Therapeutics Product
Table 124. Concord Biotech Revenue in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Concord Biotech Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Others Features
Figure 5. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Autoimmune Hemolytic Anemia Therapeutics Report Years Considered
Figure 10. Global Autoimmune Hemolytic Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Autoimmune Hemolytic Anemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Autoimmune Hemolytic Anemia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Autoimmune Hemolytic Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Hemolytic Anemia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Autoimmune Hemolytic Anemia Therapeutics Revenue in 2020
Figure 17. Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Autoimmune Hemolytic Anemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Autoimmune Hemolytic Anemia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Autoimmune Hemolytic Anemia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Autoimmune Hemolytic Anemia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Autoimmune Hemolytic Anemia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Autoimmune Hemolytic Anemia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Autoimmune Hemolytic Anemia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Autoimmune Hemolytic Anemia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Autoimmune Hemolytic Anemia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Autoimmune Hemolytic Anemia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Autoimmune Hemolytic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amneal Pharmaceuticals Inc Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 59. Baxter International Inc Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 61. Incyte Corp Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 62. Kezar Life Sciences Inc Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 63. Pfizer Inc Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 64. Rigel Pharmaceuticals Inc Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 67. Horizo​​n Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 68. Genentech Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 69. Zydus Cadila Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 70. Concord Biotech Revenue Growth Rate in Autoimmune Hemolytic Anemia Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---